Sort
25,944 grants matching “neurodegeneration”
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD
$801,547Kyrana Tsapkini · Johns Hopkins University · R01 · FY2023 · AG
Control of Cholesterol Metabolism --Bile Acid Transport
$801,514John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2007 · HL
Big data and small molecules for Alzheimer's disease
$801,219Weiming Xia · Boston University Medical Campus · R01 · FY2025 · AG
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkers
$801,126Clifford Jack · Mayo Clinic Rochester · R37 · FY2023 · AG
Project 3 (BNI)-Cholinergic alteration in mild cognitive impairment
$801,058Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2023 · AG
Mapping of the intrinsic and extrinsic cerebellar connectome at ultra high resolution with expert neuroanatomical curation
$801,049Lauren Jean O'Donnell · Brigham And Women'S Hospital · R01 · FY2025 · MH
Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's Disease
$800,972Yadong Huang · J. David Gladstone Institutes · R01 · FY2025 · AG
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$800,931Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2021 · NS
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$800,931Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2019 · NS
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$800,931Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2020 · NS
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$800,931Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2022 · NS
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS
$800,773Clive Niels Svendsen · Cedars-Sinai Medical Center · UG3 · FY2021 · TR
Project 3 (BNI)-Cholinergic alteration in mild cognitive impairment
$800,758Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2022 · AG
ERAD-STING Crosstalk in Microglia: Unraveling the Pathogenesis of Alzheimer's Disease
$800,166Ling Qi · University Of Virginia · R01 · FY2025 · AG
Sex-Specific Genetic Drivers of Alzheimer's Disease Endophenotypes
$800,024Logan C Dumitrescu · Vanderbilt University Medical Center · R01 · FY2023 · AG
Cognitive Computing of Alzheimer's Disease Genes and Risk
$799,998Olivier Lichtarge · Baylor College Of Medicine · U01 · FY2021 · AG
Cognitive Computing of Alzheimer's Disease Genes and Risk
$799,998Olivier Lichtarge · Baylor College Of Medicine · U01 · FY2023 · AG
Cognitive Computing of Alzheimer's Disease Genes and Risk
$799,998Olivier Lichtarge · Baylor College Of Medicine · U01 · FY2024 · AG
Cognitive Computing of Alzheimer's Disease Genes and Risk
$799,998Olivier Lichtarge · Baylor College Of Medicine · U01 · FY2022 · AG
Project 3 (BNI)-Cholinergic alteration in mild cognitive impairment
$799,857Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2021 · AG
Systems Genetics Analysis of Resilience to Tauopathy in ADRD
$799,700Karen E Duff · University College London · R01 · FY2025 · AG
Hypothalamic AgRP Neurons Are Determinants of Healthy Lifespan and Higher Brain
$799,450Tamas L Horvath · Yale University · DP1 · FY2013 · DK
Alzheimer's Abeta, Tau, Apolipoproteins and Blood-brain barrier
$799,216Berislav V Zlokovic · University Of Southern California · R01 · FY2021 · NS
CSF Oligomeric α-synuclein targeted nano scavengers as a Parkinson's disease theranostic
$799,127Eric Tanifum · Baylor College Of Medicine · R01 · FY2024 · NS
Explore roles of HSV-1 in Alzheimer's disease using mouse models
$798,989Pinghui Feng · University Of Southern California · R01 · FY2023 · AG